VKH
AIM

Virtu KCG Holdings’s AIM ImmunoTech AIM Stock Holding History

Virtu KCG Holdings’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2
Closed -$13K – 4240
2016
Q3 		$13K Buy
2
+1
+100% +$7.02K ﹤0.01% 2958
2016
Q2 		$3K Sell
1
-2
-67% -$13.1K ﹤0.01% 2895
2016
Q1 		$22K Buy
3
+2
+200% +$12.8K ﹤0.01% 2589
2015
Q4 		$6K Sell
1
-1
-50% -$6.8K ﹤0.01% 3406
2015
Q3 		$18K Sell
2
-1
-33% -$9.61K ﹤0.01% 3179
2015
Q2 		$29K Buy
3
+2
+200% +$24.8K ﹤0.01% 3153
2015
Q1 		$9K Sell
1
-5
-83% -$62.6K ﹤0.01% 3018
2014
Q4 		$83K Buy
6
+5
+500% +$74.6K ﹤0.01% 3295
2014
Q3 		$12K Buy
+1
New +$15.4K ﹤0.01% 3506
2014
Q2 		– Sell
-1
Closed -$17.9K – 3567
2014
Q1 		$22K Hold
1
– – ﹤0.01% 3425
2013
Q4 		$9K Hold
1
– – ﹤0.01% 3742
2013
Q3 		$13K Buy
+1
New +$12.6K ﹤0.01% 3642

Other funds holding AIM

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAM
Occidental Asset Management Burlingame, California $844M AUM 20.95% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Virtu KCG Holdings's AIM Position: Q4 2016 in Review

Virtu KCG Holdings sold out of AIM ImmunoTech (AIM) in Q4 2016, closing a stake of 2 shares — an estimated $13K sold.

Virtu KCG Holdings first reported a position in AIM in Q3 2013 and held it in 12 quarters. The position peaked at $83K in Q4 2014. 14 funds tracked by Wall St. Rank hold AIM as of Q4 2016.

  • Virtu KCG Holdings reported no remaining AIM ImmunoTech position as of Q4 2016 after selling out during the quarter.
  • Virtu KCG Holdings sold 2 AIM ImmunoTech shares in Q4 2016, an estimated $13K.
  • Virtu KCG Holdings first reported a position in AIM ImmunoTech in Q3 2013 and held it in 12 quarters.
  • Virtu KCG Holdings's AIM ImmunoTech position peaked at $83K in Q4 2014.
  • 14 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.